|
|
|
|
|
|
|
|
|
|
|
References
1. Abell E, Morgan K. The treatment of
idiopathic hyperhidrosis by glycopyrronium bromide and tap
water iontophoresis. Br J Dermatol. 1974;91:87-91.
2. Adar R, Kurchin A, Zweig A, Mozes M. Palmar hyperhidrosis
and its surgical treatment: a report of 100 cases. Ann Surg.
1977;186:34-41.
3. Akins DL, Meisenheimer JL, Dobson RL. Efficacy of the
Drionic unit in the treatment of hyperhidrosis. J Am Acad
Dermatol. 1987;16:828-832.
4. Altman RS, Schwartz RA. Emotionally induced hyperhidrosis.
Cutis. 2002;69:336-338.
5. Amir M, Arish A, Weinstein Y, Pfeffer M, Levy Y. Impairment
in quality of life among patients seeking surgery for hyperhidrosis
(excessive sweating): preliminary results. Isr J Psychiatry
Relat Sci. 2000;37:25-31.
6. Andrews BT, Rennie JA. Predicting changes in the distribution
of sweating following thoracoscopic sympathectomy. Br J
Surg. 1997;84:1702-1704.
7. Anliker MD, Kreyden OP. Tap water iontophoresis. Curr
Probl Dermatol. 2002;30:48-56.
8. Aoki KR. Physiology and pharmacology of therapeutic
botulinum neurotoxins. Curr Probl Dermatol. 2002;30:107-116.
9. Atkins JL, Butler PE. Hyperhidrosis: a review of current
management. Plast Reconstr Surg. 2002;110:222-228.
10. Atkinson JL, Feeley RD. Sympathotomy instead of sympathectomy
for palmar hyperhidrosis: minimizing postoperative compensatory
hyperhidrosis. Mayo Clin Proc. 2003;78:167-172.
11. Baumann LS, Halem ML. Systemic adverse effects after
botulinum toxin type B (myobloc) injections for the treatment
of palmar hyperhidrosis. Arch Dermatol. 2003;139:226-227.
12. Beerens AJ, Snow GB. Botulinum toxin A in the treatment
of patients with Frey syndrome. Br J Surg. 2002;89:116-119.
13. Belin EE, Polo J. Treatment of compensatory hyperhidrosis
with botulinum toxin type A. Cutis. 2003;71:68-70.
14. Benohanian A, Dansereau A, Bolduc C, Bloom E. Localized
hyperhidrosis treated with aluminum chloride in a salicylic
acid gel base. Int J Dermatol. 1998;37:701-703.
15. Bergstresser PR, Quero R. Treatment of hyperhidrosis
with topical methenamine. Int J Dermatol. 1976;15:452-455.
16. Birner P, Heinzl H, Schindl M, Pumprla J, Schnider
P. Cardiac autonomic function in patients suffering from
primary focal hyperhidrosis. Eur Neurol. 2000;44:112-116.
17. Black MJ, Gunn A. The management of Frey's syndrome
with aluminium chloride hexahydrate antiperspirant. Ann
R Coll Surg Engl. 1990;72:49-52.
18. Blaheta HJ, Deusch H, Rassner G, Vollert B. Intravenous
regional anesthesia (Bier's block) is superior to a peripheral
nerve block for painless treatment of plantar hyperhidrosis
with botulinum toxin. J Am Acad Dermatol. 2003;48:302-304.
19. Böni R. Generalized hyperhidrosis and its systemic
treatment. Curr Probl Dermatol. 2002;30:44-47.
20. Botox prescribing information. Irvine, Calif: Allergan
Inc; 2002.
21. Botox Cosmetic prescribing information. Irvine, Calif:
Allergan Inc; 2002.
22. Bouman HD, Grunewald Lentzer EM. The treatment of
hyperhidrosis of hands and feet with constant current. Am
J Phys Med. 1952;31:158-169.
23. Brandrup F, Larsen PO. Axillary hyperhidrosis: local
treatment with aluminum chloride hexahydrate 25% in absolute
ethanol. Acta Derm Venereol. 1978;58:461-465.
24. Bushara KO, Park DM. Botulinum toxin and sweating.
J Neurol Neurosurg Psychiatry. 1994;57:1437-1438.
25. Canaday BR, Stanford RH. Propantheline bromide in
the management of hyperhidrosis associated with spinal cord
injury. Ann Pharmacother. 1995;29:489-492.
26. Chen HJ, Lu K, Liang CL. Transthoracic endoscopic
T-2, 3 sympathectomy for facial hyperhidrosis. Auton Neurosci.
2001;93:91-94.
27. Chuang KS, Liu JC. Long-term assessment of percutaneous
stereotactic thermocoagulation of upper thoracic ganglionectomy
and sympathectomy for palmar and craniofacial hyperhidrosis in
1742 cases. Neurosurgery. 2002;5:963-969.
28. Cina CS, Clase CM. The Illness Intrusiveness Rating
Scale: a measure of severity in individuals with hyperhidrosis.
Qual Life Res. 1999;8:693-698.
29. Collin J, Whatling P. Treating hyperhidrosis. Surgery
and botulinum toxin are treatments of choice in severe cases.
BMJ. 2000;320:1221-1222.
30. Cullen SI. Topical methenamine therapy for hyperhidrosis.
Arch Dermatol. 1975;111:1158-1160.
31. Dahl JC, Glent-Madsen L. Treatment of hyperhidrosis
manuum by tap water iontophoresis. Acta Derm Venereol. 1989;69:346-348.
32. Davidson JR, Foa EB, Connor KM, Churchill LE. Hyperhidrosis
in social anxiety disorder. Prog Neuropsychopharmacol Biol
Psychiatry. 2002;26:1327-1331.
33. de Almeida AR, Kadunc BV, de Oliveira EM. Improving
botulinum toxin therapy for palmar hyperhidrosis: wrist
block and technical considerations. Dermatol Surg. 2001;27:34-36.
34. Dobson RL. Treatment of hyperhidrosis. Arch Dermatol.
1987;123:883-884.
35. Drott C, Gothberg G, Claes G. Endoscopic transthoracic
sympathectomy: an efficient and safe method for the treatment
of hyperhidrosis. J Am Acad Dermatol. 1995;33:78-81.
36. Feder R. Clonidine treatment of excessive sweating.
J Clin Psychiatry. 1995;56:35.
37. Frankland JC, Seville RH. The treatment of hyperhidrosis
with topical propantheline—a new technique. Br J Dermatol.
1971;85:577-581.
38. Fujita M, Mann T, Mann O, Berg D. Surgical pearl:
use of nerve blocks for botulinum toxin treatment of palmar-plantar
hyperhidrosis. J Am Acad Dermatol. 2001;45:587-589.
39. Garber A, Gregory RJ. Benztropine in the treatment
of venlafaxine-induced sweating. J Clin Psychiatry. 1997;58:176-177.
40. Geiges ML. The history of botulism. Curr Probl Dermatol.
2002;30:77-93.
41. Glent-Madsen L, Dahl JC. Axillary hyperhidrosis. Local
treatment with aluminium-chloride hexahydrate 25% in absolute
ethanol with and without supplementary treatment with triethanolamine.
Acta Derm Venereol. 1988;68:87-89.
42. Glogau RG. Botulinum A neurotoxin for axillary hyperhidrosis.
No sweat Botox. Dermatol Surg. 1998;24:817-819.
43. Glogau RG. Treatment of palmar hyperhidrosis with
botulinum toxin. Semin Cutan Med Surg. 2001;20:101-108.
44. Goh CL. Aluminum chloride hexahydrate versus palmar
hyperhidrosis. Evaporimeter assessment. Int J Dermatol.
1990;29:368-370.
45. Goodman G. Diffusion and short-term efficacy of botulinum
toxin a after the addition of hyaluronidase and its possible
application for the treatment of axillary hyperhidrosis.
Dermatol Surg. 2003;29:533-538.
46. Gossot D, Galetta D, Pascal A, et al. Long-term results of
endoscopic thoracic sympathectomy for upper limb hyperhidrosis.
Ann Thorac Surg. 2003;75:1075-1079.
47. Grice K, Sattar H, Baker H. Treatment of idiopathic
hyperhidrosis with iontophoresis of tap water and poldine
methosulphate. Br J Dermatol. 1972;86:72-78.
48. Groscurth P. Anatomy of sweat glands. Curr Probl Dermatol.
2002;30:1-9.
49. Hafner J, Beer GM. Axillary sweat gland excision.
Curr Probl Dermatol. 2002;30:57-63.
50. Heckmann M. Complications in patients with palmar
hyperhidrosis treated with transthoracic endoscopic sympathectomy.
Neurosurgery. 1998;42:1403-1404.
51. Heckmann M. Hyperhidrosis of the axilla. Curr Probl
Dermatol. 2002;30:149-155.
52. Heckmann M, Breit S, Ceballos-Baumann A, Schaller
M, Plewig G. Side-controlled intradermal injection of botulinum
toxin A in recalcitrant axillary hyperhidrosis. J Am Acad
Dermatol. 1999;41:987-990.
53. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum
toxin A for axillary hyperhidrosis (excessive sweating).
N Engl J Med. 2001;344:488-493.
54. Heckmann M, Schaller M, Breit S, Plewig G. Evaluation
of therapeutic success of hyperhidrosis therapy. Arch Dermatol.
2001;137:94.
55. Herbst F, Plas EG, Fugger R, Fritsch A. Endoscopic
thoracic sympathectomy for primary hyperhidrosis of the
upper limbs. A critical analysis and long-term results of
480 operations. Ann Surg. 1994;220:86-90.
56. Hill AC, Baker GF, Jansen GT. Mechanism of action
of iontophoresis in the treatment of palmar hyperhidrosis.
Cutis. 1981;28:69-70,72.
57. Hölzle E. Pathophysiology of sweating. Curr Probl
Dermatol. 2002;30:10-22.
58. Hölzle E. Topical pharmacological treatment.
Curr Probl Dermatol. 2002;30:30-43.
59. Hölzle E, Braun-Falco O. Structural changes in
axillary eccrine glands following long-term treatment with
aluminium chloride hexahydrate solution. Br J Dermatol.
1984;110:399-403.
60. Hsu CP, Shia SE, Hsia JY, Chuang CY, Chen CY. Experiences
in thoracoscopic sympathectomy for axillary hyperhidrosis
and osmidrosis: focusing on the extent of sympathectomy.
Arch Surg. 2001;136:1115-1117.
61. Huang W, Foster JA, Rogachefsky AS. Pharmacology of
botulinum toxin. J Am Acad Dermatol. 2000;43:249-259.
62. Huh CH, Han KH, Seo KI, Eun HC. Botulinum toxin treatment
for a compensatory hyperhidrosis subsequent to an upper
thoracic sympathectomy. J Dermatolog Treat. 2002;13:91-93.
63. Hund M, Kinkelin I, Naumann M, Hamm H. Definition of
axillary hyperhidrosis by gravimetric assessment. Arch Dermatol.
2002;138:539-541.
64. Imhof M, Zacherl J, Plas EG, Herbst F, Jakesz R, Fugger
R. Long-term results of 45 thoracoscopic sympathicotomies
for primary hyperhidrosis in children. J Pediatr Surg. 1999;34:1839-1842.
65. Iwase S, Ikeda T, Kitazawa H, Hakusui S, Sugenoya
J, Mano T. Altered response in cutaneous sympathetic outflow
to mental and thermal stimuli in primary palmoplantar hyperhidrosis.
J Auton Nerv Syst. 1997;64:65-73.
66. James WD, Schoomaker EB, Rodman OG. Emotional eccrine
sweating. A heritable disorder. Arch Dermatol. 1987;123:925-929.
67. Juhlin L, Evers H, Broberg F. Inhibition of hyperhidrosis
by topical application of a local anesthetic composition.
Acta Derm Venereol. 1979;59:556-559.
68. Juhlin L, Hansson H. Topical glutaraldehyde for plantar
hyperhidrosis. Arch Dermatol. 1968;97:327-330.
69. Kao MC, Chen YL, Lin JY, Hsieh CS, Tsai JC. Endoscopic
sympathectomy treatment for craniofacial hyperhidrosis.
Arch Surg. 1996;131:1091-1094.
70. Karakoç Y. Safe control of palmoplantar hyperhidrosis
with direct electrical current. Int J Dermatol. 2002;41:602-605.
71. Karamfilov T, Konrad H, Karte K, Wollina U. Lower
relapse rate of botulinum toxin A therapy for axillary hyperhidrosis
by dose increase. Arch Dermatol. 2000;136:487-490.
72. Kestenholz PB, Weder W. Thoracic sympathectomy. Curr
Probl Dermatol. 2002;30:64-76.
73. Khurana RK. Orthostatic hypotension-induced autonomic
dysreflexia. Neurology. 1987;37:1221-1224.
74. Kinkelin I, Hund M, Naumann M, Hamm H. Effective treatment
of frontal hyperhidrosis with botulinum toxin A. Br J Dermatol.
2000;143:824-827.
75. Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis.
Arch Dermatol. 2000;136:539-541.
76. Kreyden OP. Botulinum toxin: from poison to pharmaceutical.
The history of a poison that became useful to mankind. Curr
Probl Dermatol. 2002;30:94-100.
77. Kreyden OP. Rare forms of hyperhidrosis. Curr Probl
Dermatol. 2002;30:178-187.
78. Kreyden OP, Schmid-Grendelmeier P, Burg G. Idiopathic
localized unilateral hyperhidrosis: case report of successful
treatment with botulinum toxin type A and review of the
literature. Arch Dermatol. 2001;137:1622-1625.
79. Kuritzky A, Hering R, Goldhammer G, Bechar M. Clonidine
treatment in paroxysmal localized hyperhidrosis. Arch Neurol.
1984;41:1210-1211.
80. Laccourreye O, Akl E, Gutierrez-Fonseca R, Garcia
D, Brasnu D, Bonan B. Recurrent gustatory sweating (Frey
syndrome) after intracutaneous injection of botulinum toxin
type A: incidence, management, and outcome. Arch Otolaryngol
Head Neck Surg. 1999;125:283-286.
81. Laccourreye O, Bonan
B, Brasnu D, Laccourreye H. Treatment of Frey's syndrome
with topical 2% diphemanil methylsulfate (Prantal): a double-blind
evaluation of 15 patients. Laryngoscope. 1990;100:651-653.
82. Lai YT, Yang LH, Chio CC, Chen HH. Complications in
patients with palmar hyperhidrosis treated with transthoracic
endoscopic sympathectomy. Neurosurgery. 1997;41:110-113.
83. Laskawi R, Ellies M, Rodel R, Schoenebeck C. Gustatory
sweating: clinical implications and etiologic aspects. J
Oral Maxillofac Surg. 1999;57:642-648.
84. Laskawi R, Rohrbach S. Frey's syndrome. Treatment
with botulinum toxin. Curr Probl Dermatol. 2002;30:170-177.
85. Levit F. Simple device for treatment of hyperhidrosis
by iontophoresis. Arch Dermatol. 1968;98:505-507.
86. Levit F. Treatment of hyperhidrosis by tap water iontophoresis.
Cutis. 1980;26:192-194.
87. LeWitt P. Hyperhidrosis and hypothermia responsive
to oxybutynin. Neurology. 1988;38:506-507.
88. Lillis PJ, Coleman WP 3rd. Liposuction for treatment
of axillary hyperhidrosis. Dermatol Clin. 1990;8:479-482.
89. Lin TS, Chou MC. Needlescopic thoracic sympathetic
block by clipping for craniofacial hyperhidrosis: an analysis
of 28 cases. Surg Endosc. 2002;16:1055-1058.
90. Lowe PL, Cerdan-Anz S, Lowe NJ. Botulinum toxin type
a in the treatment of bilateral primary axillary hyperhidrosis:
efficacy and duration with repeated treatments. Dermatol
Surg. 2003;29:545-548.
91. Lowe NJ, Yamauchi PS, Lask GP, Patnaik R, Iyer S.
Efficacy and safety of botulinum toxin type a in the treatment
of palmar hyperhidrosis: a double-blind, randomized, placebo-controlled
study. Dermatol Surg. 2002;28:822-827.
92. Luh JY, Blackwell TA. Craniofacial hyperhidrosis successfully
treated with topical glycopyrrolate. South Med J. 2002;9:756-758.
93. Manca D, Valls-Sole J, Callejas MA. Excitability recovery
curve of the sympathetic skin response in healthy volunteers
and patients with palmar hyperhidrosis. Clin Neurophysiol.
2000;111:1767-1770.
94. Matthews BD, Bui HT, Harold KL, et al. Thoracoscopic sympathectomy
for palmaris hyperhidrosis. South Med J. 2003;96:254-258.
95. Moraru E, Auff E, Schnider P. Hyperhidrosis of the
palms and soles. Curr Probl Dermatol. 2002;30:156-169.
96. Myobloc prescribing information. South San Francisco,
Calif: Elan Pharmaceuticals Inc; 2000.
97. Naumann M. Evidence-based medicine: botulinum toxin
in focal hyperhidrosis. J Neurol. 2001;248(suppl 1):31-33.
98. Naumann M, Flachenecker P, Brocker EB, Toyka KV, Reiners
K. Botulinum toxin for palmar hyperhidrosis. Lancet. 1997;34:252.
99. Naumann M, Hamm H. Treatment of axillary hyperhidrosis.
Br J Surg. 2002;89:259-261.
100. Naumann MK, Hamm H, Lowe NJ. Effect of botulinum
toxin type A on quality of life measures in patients with
excessive axillary sweating: a randomized controlled trial.
Br J Dermatol. 2002;147:1218-1226.
101. Naumann M, Hofmann U, Bergmann I, Hamm H, Toyka KV,
Reiners K. Focal hyperhidrosis: effective treatment with
intracutaneous botulinum toxin. Arch Dermatol. 1998;134:301-304.
102. Naumann M, Lowe NJ. Botulinum toxin type A in treatment
of bilateral primary axillary hyperhidrosis: randomised,
parallel group, double blind, placebo controlled trial.
BMJ. 2001;323:596-599.
103. Naumann M, Lowe NJ, Kumar CR, Hamm H. Botulinum toxin
type a is a safe and effective treatment for axillary hyperhidrosis
over 16 months: a prospective study. Arch Dermatol. 2003;139:731-736.
104. Noppen M, Sevens C, Gerlo E, Vincken W. Plasma catecholamine
concentrations in essential hyperhidrosis and effects of
thoracoscopic D2-D3 sympathicolysis. Eur J Clin Invest.
1997;27:202-205.
105. Odderson IR. Long-term quantitative benefits of botulinum
toxin type A in the treatment of axillary hyperhidrosis.
Dermatol Surg. 2002;28:480-483.
106. Orteu CH, McGregor JM, Almeyda JR, Rustin MH. Recurrence
of hyperhidrosis after endoscopic transthoracic sympathectomy—case
report and review of the literature. Clin Exp Dermatol.
1995;20:230-233.
107. Parslew R, Lewis-Jones MS. Localized unilateral hyperhidrosis
secondary to an eccrine naevus. Clin Exp Dermatol. 1997;22:246-247.
108. Proebstle TM. Gravimetrically controlled efficacy
of subcorial curettage: a prospective study for treatment
of axillary hyperhidrosis. Dermatol Surg. 2002;28:1022-1026.
109. Rayner CR, Ritchie ID, Stark GP. Axillary hyperhidrosis,
20% aluminum chloride hexahydrate, and surgery. Br Med J.
1980;280:1168.
110. Reinauer S, Neusser A, Schauf G, Holzle E. Iontophoresis
with alternating current and direct current offset (AC/DC
iontophoresis): a new approach for the treatment of hyperhidrosis.
Br J Dermatol. 1993;129:166-169.
111. Restivo DA, Lanza S, Patti F, et al. Improvement of diabetic autonomic
gustatory sweating by botulinum toxin type A. Neurology.
2002;59:1971-1973.
112. Rex LO, Drott C, Claes G, Gothberg G, Dalman P. The
Boras experience of endoscopic thoracic sympathicotomy for
palmar, axillary, facial hyperhidrosis and facial blushing.
Eur J Surg. 1998;580(suppl):23-26.
113. Ro KM, Cantor RM, Lange KL, Ahn SS. Palmar hyperhidrosis:
evidence of genetic transmission. J Vasc Surg. 2002;35:382-386.
114. Rompel R, Scholz S. Subcutaneous curettage vs. injection
of botulinum toxin A for treatment of axillary hyperhidrosis.
J Eur Acad Dermatol Venereol. 2001;15:207-211.
115. Rossetto O, Seveso M, Caccin P, Montecucco C. Botulinum
neurotoxins are metalloproteases specific for SNARE proteins
involved in neuroexocytosis. Curr Probl Dermatol. 2002;30:117-125.
116. Ruchinskas RA. The relationship of psychopathology
and hyperhidrosis. Br J Dermatol. 2002;147: 733-735.
117. Saadia D, Voustianiouk A, Wang AK, Kaufmann H. Botulinum
toxin type A in primary palmar hyperhidrosis: randomized,
single-blind, two-dose study. Neurology. 2001;57:2095-2099.
118. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat
glands and their disorders. I. Normal sweat gland function.
J Am Acad Dermatol. 1989;20:537-563.
119. Sato K, Kang WH, Saga K, Sato KT. Biology of sweat
glands and their disorders. II. Disorders of sweat gland
function. J Am Acad Dermatol. 1989;20:713-726.
120. Sato K, Sato F. Sweat secretion by human axillary
apoeccrine sweat gland in vitro. Am J Physiol. 1987;252:R181-R187.
121. Sato K, Timm DE, Sato F, et al. Generation and transit pathway
of H+ is critical for inhibition of palmar sweating by iontophoresis
in water. J Appl Physiol. 1993;75:2258-2264.
122. Schaffner R, Kreyden OP. Complications and side-effects
of botulinum toxin A. Curr Probl Dermatol. 2002;30:141-148.
123. Schnider P, Binder M, Auff E, Kittler H, Berger T,
Wolff K. Double-blind trial of botulinum A toxin for the
treatment of focal hyperhidrosis of the palms. Br J Dermatol.
1997;136:548-552.
124. Schnider P, Moraru E, Kittler H, et al. Treatment of focal hyperhidrosis with
botulinum toxin type A: long-term follow-up in 61 patients.
Br J Dermatol. 2001;145:289-293.
125. Schnider P, Moraru E, Kittler H, Voller B, Auff E.
High-dose botulinum toxin type A for axillary hyperhidrosis.
Arch Dermatol. 2000;136:1567.
126. Scholes KT, Crow KD, Ellis JP, Harman RR, Saihan
EM. Axillary hyperhidrosis treated with alcoholic solution
of aluminium chloride hexahydrate. Br Med J. 1978;2:84-85.
127. Shachor D, Jedeikin R, Olsfanger D, Bendahan J, Sivak
G, Freund U. Endoscopic transthoracic sympathectomy in the
treatment of primary hyperhidrosis. A review of 290 sympathectomies.
Arch Surg. 1994;129:241-244.
128. Shaw JE, Abbott CA, Tindle K, Hollis S, Boulton AJ.
A randomised controlled trial of topical glycopyrrolate,
the first specific treatment for diabetic gustatory sweating.
Diabetologia. 1997;40:299-301.
129. Shen JL, Lin GS, Li WM. A new strategy of iontophoresis
for hyperhidrosis. J Am Acad Dermatol. 1990;22:239-241.
130. Shrivastava SN, Singh G. Tap water iontophoresis
in palmo-plantar hyperhidrosis. Br J Dermatol. 1977;96:189-195.
131. Sloan JB, Soltani K. Iontophoresis in dermatology.
A review. J Am Acad Dermatol. 1986;15:671-684.
132. Solomon BA, Hayman R. Botulinum toxin type A therapy
for palmar and digital hyperhidrosis. J Am Acad Dermatol.
2000;42:1026-1029.
133. Stolman LP. Treatment of excess sweating of the palms
by iontophoresis. Arch Dermatol. 1987;123:893-896.
134. Stolman LP. Treatment of hyperhidrosis. Dermatol
Clin. 1998;16:863-869.
135. Strutton DR, Kowalski J, Glaser DA, Stang P. Impact
of daily activities in the US for individuals with axillary
hyperhidrosis: results from a national consumer panel. Poster
presentation at the Annual Meeting of the American Academy
of Dermatology; March 21-26, 2003; San Francisco, Calif.
Poster abstract P363.
136. Strutton DR, Kowalski J, Glaser DA, Stang P. US prevalence
of hyperhidrosis: results from a national consumer panel.
Poster presentation at the Annual Meeting of the American
Academy of Dermatology; March 21-26, 2003; San Francisco,
Calif. Poster abstract P362.
137. Sung SW, Kim YT, Kim JH. Ultra-thin needle thoracoscopic
surgery for hyperhidrosis with excellent cosmetic effects.
Eur J Cardiothorac Surg. 2000;17:691-696.
138. Swartling C, Farnstrand C, Abt G, Stalberg E, Naver
H. Side-effects of intradermal injections of botulinum A
toxin in the treatment of palmar hyperhidrosis: a neurophysiological
study. Eur J Neurol. 2001;8:451-456.
139. Swartling C, Naver H, Lindberg M. Botulinum A toxin
improves life quality in severe primary focal hyperhidrosis.
Eur J Neurol. 2001;8:247-252.
140. Swinehart JM. Treatment of axillary hyperhidrosis:
combination of the starch-iodine test with the tumescent
liposuction technique. Dermatol Surg. 2000;26:392-396.
141. Tan SR, Solish N. Long-term efficacy and quality
of life in the treatment of focal hyperhidrosis with botulinum
toxin A. Dermatol Surg. 2002;28:495-499.
142. Tashjian EA, Richter KJ. The value of propoxyphene
hydrochloride (Darvon) for the treatment of hyperhidrosis
in the spinal cord injured patient: an anecdotal experience
and case reports. Paraplegia. 1985;23:349-353.
143. Telaranta T. Treatment of social phobia by endoscopic
thoracic sympathicotomy. Eur J Surg. 1998;580(suppl):27-32.
144. Tkach JR. Indomethacin treatment of generalized hyperhidrosis.
J Am Acad Dermatol. 1982;6:545.
145. Tögel B, Greve B, Raulin, C. Current therapeutic
strategies for hyperhidrosis: a review. Eur J Dermatol. 2002;12:219-223.
146. Torch EM. Remission of facial and scalp hyperhidrosis
with clonidine hydrochloride and topical aluminum chloride.
South Med J. 2000;93:68-69.
147. Wang L, Hilliges M, Gajecki M, Marcusson JA, Johansson
O. No change in skin innervation in patients with palmar
hyperhidrosis treated with tap-water iontophoresis. Br J
Dermatol. 1994;131:742-743.
148. White JW Jr. Treatment of primary hyperhidrosis.
Mayo Clin Proc. 1986;61:951-956.
149. Wollina U, Karamfilov T, Konrad H. High-dose botulinum
toxin type A therapy for axillary hyperhidrosis markedly
prolongs the relapse-free interval. J Am Acad Dermatol.
2002;46:536-540.
150. Yamamoto H, Kanehira A, Kawamura M, Okada M, Ohkita
Y. Needlescopic surgery for palmar hyperhidrosis. J Thorac
Cardiovasc Surg. 2000;120:276-279.
151. Zacherl J, Huber ER, Imhof M, Plas EG, Herbst F,
Fugger R. Long-term results of 630 thoracoscopic sympathicotomies
for primary hyperhidrosis: the Vienna experience. Eur J Surg.
1998;580(suppl):43-46.
152. Zacherl J, Imhof M, Huber ER, et al. Video assistance reduces complication
rate of thoracoscopic sympathicotomy for hyperhidrosis.
Ann Thorac Surg. 1999;68:1177-1181.
153. Naumann MK, Hamm H, Spalding JR,
Kowalski JW, Lee JT. Comparing the quality of life effect
of primary focal hyperhidrosis as assessed by the Dermatology
Life Quality Index (DLQI). Paper presented at the July 2003
meeting of the American Academy of Dermatology; July 25-29,
2003; Chicago, Ill.
Back to top
|
|
|
|
|
|
 |
|
|
 |
|
|
|
|
|
 |
|
|
List your practice or search for colleagues. |
|
|
 |
|
|
|
|
|
 |
|
|
|
|
|
 |
|
 |
|
|
|
|
| |
| |
|
|
